Cannabis Drug Company Zynerba Is Gearing Up For A Big Summer

Zynerba is targeting adult epilepsy, arthritis and Fragile X Syndrome with its synthetic cannabis drugs. Next milestones are expected this summer and equity analysts are on board.

Source: Forbes.com Healthcare News - January 26, 2017 Category: Pharmaceuticals Authors: Debra Borchardt, Contributor Tags: NASDAQ:ZYNE NASDAQ:GWPH Source Type: news